CLINICAL_TRIALS
research
· 2025-11-17
Clinical Trial Update: Identify the Optimal TMS Target to Modulate Reward Activity [NA]
Summary
Rutgers is recruiting for a study to identify the optimal transcranial magnetic stimulation (TMS) target to modulate reward activity in nicotine use disorder.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Rutgers, The State University of New Jersey | Conditions: Nicotine Use Disorder | NA | Status: RECRUITING